Top Markets
Coin of the day
Athens Medical C.S.A. Athens Medical C.S.A.

Athens Medical C.S.A.

IATR
Rangering i aksjer #19370
Athens Medical C.S.A., together with its affiliated companies, operates and... Athens Medical C.S.A., together with its affiliated companies, operates and holds ownership of hospital facilities both within Greece and on an international scale. The organization delivers extensive diagnostic and treatment options for various cancers, such as those affecting the breast, gastrointestinal system, blood, liver and pancreas, lungs, prostate, skin, bladder, kidneys, and female reproductive organs. Additionally, it offers advanced robotic surgery, neurosurgical procedures, spinal operations, and therapies for cardiac ailments. Its services encompass a broad range of orthopedic specialties, addressing conditions of the foot and ankle, hand and wrist, hip, knee, shoulder, and spine, in addition to treating sports-related injuries. The company also provides care for chronic conditions including diabetes, endocrine disorders, heart failure, high blood pressure, pain management, respiratory system issues, stroke, and thyroid conditions. Furthermore, Athens Medical C.S.A. runs wellness and preventative health centers and performs cosmetic and reconstructive plastic surgery. The group is also involved in medical education, training, and practical service provision, alongside offering patient care guidance. It currently manages eight hospital units, which collectively feature 1,200 beds. Founded in 1984, Athens Medical C.S.A. is headquartered in Athens, Greece.
Aksjekurs
$1.90
Sist synkronisert: 2026-08-25
Markedsverdi
$164.61M
Endring (1 dag)
-1.23%
Endring (1 år)
-24.88%
Land
GR
Handel Athens Medical C.S.A. (IATR)

Kategori

P/E-forhold for Athens Medical C.S.A. (IATR)
P/E-forhold per 2026 TTM: 0
Ifølge Athens Medical C.S.A. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet en P/E på 0.
P/E-forholdshistorikk for Athens Medical C.S.A. fra 2026 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
Ikke nok data for de angitte datoene.
P/E-forhold for lignende selskaper eller konkurrenter
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.